Results 31 to 40 of about 27,602 (209)

Edoxaban: an update on the new oral direct factor Xa inhibitor. [PDF]

, 2014
Edoxaban is a once-daily oral anticoagulant that rapidly and selectively inhibits factor Xa in a concentration-dependent manner. This review describes the extensive clinical development program of edoxaban, including phase III studies in patients with ...
Camm, AJ, Bounameaux, H, A. John Camm, Henri Bounameaux   +3 more
core   +1 more source

Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients

Clinical Medicine Insights: Blood Disorders, 2019
Background: The appropriate dose of enoxaparin for venous thromboembolism (VTE) prophylaxis in low body weight patients is unknown. Objective: The aim of this study is to evaluate the impact of enoxaparin dosing on major and minor bleeding events in low ...
Daniel Dybdahl, Grant Walliser, Michelle Pershing, Christy Collins, David Robinson   +4 more
doaj   +1 more source

Venous Thromboembolism Prophylaxis with Enoxaparin Versus Unfractionated Heparin in Patients with Low Body Weight

Plasmatology, 2023
Background Although reduced doses of enoxaparin have been studied in low body weight patients, no study has directly compared enoxaparin to unfractionated heparin for venous thromboembolism (VTE) prophylaxis in this population. Objective To determine the
David Michael Kaylor PharmD, Regan Merrell Wade PharmD, BCPS, Kathryn Brinkley Chappell PharmD, BCPS, Meredith Huff Niemann PharmD, BCPS, Vanessa Marie VanArsdale PharmD, BCPS   +4 more
doaj   +1 more source

Comparison of Intravenous Enoxaparin with Subcutaneous Enoxaparin in Preventing Venous Thromboembolism in Patients Admitted to Intensive Care Unit

Archives of Anesthesia and Critical Care, 2020
Background: The use of subcutaneous enoxaparin is a usual method for preventing venous thromboembolism (VTE) in the intensive care unit (ICU) patients, but adequate absorption of the drug is not reliable due to the illness intensity, existing edema and ...
Masoum Khoshfetrat, Majid Khorram, Aliakbar Keykha, Hossein Ansari   +3 more
doaj   +1 more source

Therapeutic Potential of Enoxaparin in Lichen Planus: Exploring Reasons for Inconsistent Reports

Frontiers in Pharmacology, 2018
Lichen planus (LP) is an uncommon mucocutaneous inflammatory condition, that is immunologically mediated, typically pruritic and often recurs. The currently advocated therapies are either not highly effective or associated with severe side effects ...
Rahul P. Patel, Madhur D. Shastri, Long Chiau Ming, Long Chiau Ming, Long Chiau Ming, Syed Tabish R. Zaidi, Gregory M. Peterson   +6 more
doaj   +1 more source

Long-term pediatric outcomes after first-trimester exposure to low-dose warfarin plus enoxaparin versus enoxaparin alone in pregnancies with mechanical heart valves: the KYBELE children study. [PDF]

BMC Cardiovasc Disord
Background Pregnant women with mechanical heart valves (MHVs) require continuous anticoagulation; however, first-trimester exposure to warfarin raises concerns regarding fetal safety.
Arici S, Yildirim AI, Keskin GY, Genc FA, Tas E, Corbacioglu S, Surekli Karakus O, Sungur M, Guner A, Gunduz S, Havan N, Gursoy MO, Ozkan M.   +12 more
europepmc   +2 more sources

Comparative efficacy and safety of anticoagulants for prevention of venous thromboembolism after hip and knee arthroplasty: A network meta-analysis

Acta Orthopaedica, 2017
Background and purpose — New oral anticoagulants have been developed to prevent venous thromboembolism (VTE) after knee or hip arthroplasty. Although there have been several network meta-analyses (NMA) to compare different regimens, an NMA including 2 ...
Min Hur, Sun-Kyung Park, Chang-Hoon Koo, Eun Dhong Jung, Pyoyoon Kang, Won Ho Kim, Jin-Tae Kim, Chul-Woo Jung, Jae-Hyon Bahk   +8 more
doaj   +1 more source

Double-Blind Randomized Clinical Trial to Examine the Pharmacokinetic and Clinical Impacts of Fixed Dose versus Weight-based Enoxaparin Prophylaxis: A Methodologic Description of the FIxed or Variable Enoxaparin (FIVE) Trial

Plastic and Reconstructive Surgery, Global Open, 2019
Venous thromboembolism is an important patient safety in plastic surgery, and multiple clinical trials in the past 10 years have provided increased understanding of the risks and benefits of venous thromboembolism prevention strategies.
Christopher J. Pannucci, MD, MS, Kory I. Fleming, MPH, Corinne Bertolaccini, PharmD, Ann Marie Prazak, PharmD, BCPS, Gregory J. Stoddard, MPH, Arash Momeni, MD   +5 more
doaj   +1 more source

Effects of a single subcutaneous dose of enoxaparin on veterinary viscoelastic coagulation monitor variables in healthy cats: Double blind, placebo controlled cross‐over trial

Journal of Veterinary Internal Medicine, 2023
Background Cats placed on anticoagulant medication require frequent monitoring. The veterinary viscoelastic coagulation monitor (VCM‐Vet) could provide a convenient and cost‐effective monitoring, enabling therapeutic decision making.
Ivayla D. Yozova, Michael S. Kent, Karl E. Jandrey   +2 more
doaj   +1 more source

Therapeutic role of enoxaparin in intra-uterine growth restriction: A randomized clinical trial

, 2021
Objective: Intrauterine growth restriction is a leading cause of perinatal mortality and morbidity. Using enoxaparin may enhance the placental circulation and improve the intrauterine growth.
Fathi, M., Nazari, F, Sharbaf, F.R., Naeiji, Z, Golshahi, F, Shirazi, M, Sahebdel, B., Naeiji, Z., Nazari, F., Fathi, M, Golshahi, F., Shirazi, M., Sharbaf, F.R, Sahebdel, B   +13 more
core